Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma

Author： Huo Xinying Zhang Qi Liu Angela M. Tang Cuiju Gong Yongling Bian Jianmin Luk John M. Xu Zhi Chen Jinfei

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.2, 2013-02, pp. : 840-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma

By Yang Cheng-lin

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1535-1541

Springer Publishing Company

Access to resources Recommend Favorite

Differences in Yes-associated protein and mRNA levels in regenerating liver and hepatocellular carcinoma

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 410-414

Spandidos Publications

Access to resources Recommend Favorite

miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2171-2178

Spandidos Publications

Access to resources Recommend Favorite

Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4101-4108

Spandidos Publications

Access to resources Recommend Favorite

Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas

By Tufail Rozina

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 743-750

Springer Publishing Company

Access to resources Recommend Favorite